The FDA has vowed not to let political pressure to approve a COVID-19 vaccine as soon as possible interfere with the regulatory process, Anthony Fauci told Reuters. Fauci’s comments come ahead of an election season in which the availability of a vaccine could influence the vote.
While some companies have expressed hopes that they will win approval for COVID-19 vaccines by the end of the year, the consensus is that the FDA is unlikely to authorize a product before the U.S. goes to the polls in early November. The likelihood that a vaccine will nearly, but not quite, be ready for market in the run up to the election has raised concerns that political pressure may lead the FDA to authorize a product prematurely.
However Fauci, the director of the National Institute of Allergy and Infectious Diseases, is confident the FDA will decide whether to approve a vaccine or not on the strength of the evidence alone.
“They promise that they are not going to let political considerations interfere with a regulatory decision,” Fauci said. “We’ve spoken explicitly about that, because the subject obviously comes up, and the people in charge of the regulatory process assure us that safety and efficacy is going to be the prime consideration.”
Fauci went on to say he is “certain of what the White House would like to see” but is yet to see “any indication of pressure at this point to do anything different than what we’re doing.”
Approving a vaccine before sufficient data are available to evaluate its safety and efficacy could cause harm. Notably, as the most closely watched prophylactics ever, postapproval safety problems with the COVID-19 products could significantly exacerbate existing vaccine hesitancy.
President Donald Trump said this week that the approval of a COVID-19 vaccine in time for the election “wouldn’t hurt” his prospects but denied that was his motivation. “I want to save a lot of lives,” Trump said. Trump is optimistic the U.S. will have a vaccine against the coronavirus before the election, putting his stance at odds with the consensus of other observers.
New patent for Bayer Healthcare drug VITRAKVI
This drug has one hundred and thirty-four patent family members in forty-two countries.
New patent for Boehringer Ingelheim drug OFEV
This drug has two hundred and twelve patent family members in fifty-one countries.
New patent expiration for Acorda drug INBRIJA
This drug has one hundred and thirty-three patent family members in twenty-six countries.
Ethereum: Is the HODLing in yet?
Physicists make electrical nanolasers even smaller
Nano-microscope gives first direct observation of the magnetic properties of 2D materials: Discovery means new class of materials and technologies
Who stole the light? Self-induced ultrafast demagnetization limits the amount of light diffracted from magnetic samples at soft x-ray energies
Brace for it – Bitcoin Futures may be nearing a tipping point
Tron, Synthetix, VeChain Price Analysis: 19 September
Here’s why Bitcoin’s ‘distracting’ volatility actually helps
Stellar Lumens, NEM, Maker Price Analysis: 19 September
Someone Remade ‘Among Us’ in VR and It’s Strangely More Fun Than the Original
Virtual Tours: The Key to a Successful School Marketing Plan
Spanish Financial Giant BBVA’s US Division Recognized as one of the Best Corporate Digital Banks in North America
Evening Reading – September 18, 2020
7 Awe Inspiring AI Techs That Transformed The Digital World
100X.VC Unveils Its Class 02 Investments
Here’s how Nasdaq-listed MicroStrategy went about buying $175m in Bitcoin
Lenovo Legion Sponsors G2 Esports as Hardware Partner
Supreme Court Justice Ruth Bader Ginsburg dies at age 87
Shanghai Electric Showcases Smart Energy Solution at China International Industrial Expo on World’s Clean Up Day
Preventive Healthcare Market Dilating in India
5 weed products Tommy Chong can’t live without
Shacknews Twitch Highlights: Rocket League, Fight Crab, and Quest 64
More gets 275 Crore INR From Amazon, Samara Capital
TikTok filed a complaint against Trump administration to block U.S. ban: Bloomberg News
Seoul Police Summons Bithumb Chairman For Interrogation
6 Crucial password security tips for everyone
‘Thank you, RBG’: Leaders react with sadness, shock to Ruth Bader Ginsburg’s death
Shack Chat: What’s your reaction to the September PlayStation 5 Showcase?
Ford Mustang Mach-E Easily Goes 300+ Miles In Norway
Apple and Sony Events – The TouchArcade Show #462
Here’s the schedule for the 2020 League of Legends World Championship
Weekend PC Download Deals for Sept. 18: Steam Pirate Sale
Shacknews Dump – September 18, 2020
India-Based Insurtech ACKO Secures $60 Million Through Latest Funding Round Led By Munich Re Ventures
Google Temporarily Removes Paytm Mobile App from Play Store Due to Supposedly Being in Violation For Gambling
TouchArcade Game of the Week: ‘Songbringer’
In Photos: Crowd gathers in front of the Supreme Court to mourn Justice Ruth Bader Ginsburg
Pinned below $11K, Bitcoin price plays second fiddle to Uniswap (UNI)
Trump nominee to replace Ruth Bader Ginsburg on Supreme Court will get Senate vote, McConnell says
Indian Government May Put EV Chargers At 69,000 Gas Pumps
The Last Time This On-Chain Metric Was This Low, Bitcoin Surged 150%
Business Insider1 week ago
Zimmer Biomet Holdings Outperform
Esports7 days ago
Valorant Ego Skins Teased
Biotechnology1 week ago
School of Science appoints 12 faculty members to named professorships
AI1 week ago
Right-sizing resources and avoiding unnecessary costs in Amazon SageMaker
AI1 week ago
How Kabbage improved the PPP lending experience with Amazon Textract
Start Ups1 week ago
Zomato IPO to Make the Company Value Equals to Its Biggest Investors
Blockchain7 days ago
eToro Launches GoodDollar and Leverages Yield Farming and Staking to Deliver a Sustainable Global Basic Income
Start Ups1 week ago
NS8, a tech startup that protects against online fraud, is now under SEC fraud investigation. CEO abruptly left last week as company lays off hundreds of employees